Vital Signs - Molecular Imaging And Computed Tomography: Technologies And Markets In Transition

 


This issue of Vital Signs, released on May 4, 2009, provides a strategic overview of changing strategies in molecular imaging and computed tomography. Additionally, a company spotlight is provided for Digirad, a leading designer, developer and manufacturer of solid state gamma cameras and a provider of in-office cardiology imaging programs. Reimbursement and regulatory news from the FDA is also provided for the week of April 20, 2009.

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

Table of Contents

Vital Signs - Molecular Imaging And Computed Tomography: Technologies And Markets In TransitionVital Signs: 4 May 2009This week's issue:




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.